<DOC>
	<DOCNO>NCT01710696</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial induce normal pubertal development girl Turner Syndrome accordance peer individual state psychosocial maturation .</brief_summary>
	<brief_title>Induction Puberty With 17-beta Estradiol Girls With Turner Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Turner Syndrome Treatment growth hormone Bone age minimum 12 year maximum 14 year Clear sign ovarian insufficiency Well document growth rate last 12 month Signs spontaneous puberty Known suspect hypersensitivity trial product Acute chronic liver disease Previous treatment estrogen Undiagnosed abnormal genital bleed Known thyroid diseases adeadequately treat Porphyria</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>